home

LATEST ONCOPRESCRIBE UPDATES

• Association between Antibiotic Use and Colorectal Cancer

• Durable Survival Benefit with First Line OPDIVO® plus YERVOY® and a Limited Course of Chemotherapy

• Late Breaking Abstract – ESMO 2021: Adjuvant KEYTRUDA® for High Risk Stage II Melanoma

• Late Breaking Abstract – ESMO 2021: Keytruda® Plus Chemotherapy in Advanced Cervical Cancer

SHOW MORE

FDA
Approvals

Meeting
Updates

Hem/Onc
Updates

Symptom
Management

NEW REGIMENS ADDED

Research Regimens

• Single Agent PEMAZYRE® - for Cholangiocarcinoma

• PARAPLATIN® and VEPESID® with IMFINZI® - for Small Cell Lung Cancer

• IMFINZI® Maintenance - Small Cell Lung Cancer

• TECENTRIQ® and ABRAXANE® - for Breast Cancer

• IDHIFA® - for Acute Myeloid Leukemia

Curbside Consultation

Lung Cancer Special Issue

Immuno-Oncology

Precision Oncology

• COVID-19 Associated Coagulopathy: Diagnosis and Management

• Dual Inhibition Improves Outcomes for Patients with BRAF-Mutated Colorectal Tumors

• Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

• FDA Approves ENDARI®, A New Treatment for Sickle Cell Disease

SHOW MORE